ArticleFrontiers in oncology2026

The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cells.

Marzia Deserti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.